An oncology expert explains how clinical and non-clinical evidence impact the clinical pathway decision-making for patients with NSCLC. Edward Arrowsmith, MD: We have a couple ways that we're tracking ...

"What has been missing is the patient's perspective," says one industry consultant. The future of clinical pathways is patient-centric: an approach that balances the long-standing focus on ...

Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer? In the article that accompanies ...

Experts who took part in Patient-Centered Oncology Care® 2021 said when guidelines recommend high-cost targeted therapies or immunotherapies, the focus must turn to areas such as imaging, diagnostic ...

As healthcare becomes more entrenched in the digital revolution, the need for an approved set of protocols for care delivery — clinical pathways — is becoming increasingly critical. Clinical pathways, ...

Since the U.S. Food and Drug Administration established its accelerated approval pathway for drugs in 1992, 112 of the 253 drugs authorized have not been confirmed as clinically effective, an ...

Expert faculties (domain specific experts in clinical, technical and analytical areas) for clinical audits and registries work closely with multidisciplinary clinical groups and patients. This faculty ...